AzTrials
AzTrials

DiabetesNCT06820775

EFFECTIVENESS OF A TRIPLE NUTRITIONAL INTERVENTION AND PHYSICAL IN PREDIABETIC PATIENRS

A study testing A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY in people with Diabetes, run by Bioaraba Health Research Institute at 1 site in Spain.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Diabetes represents a substantial burden on health care systems. People with prediabetes IGT (impaired glucose tolerance) or IFG (impaired fasting glucose) are at high risk of developing diabetes, and up to 50% progress to diabetes within 5 years. Read more about this study

Who is it for?
Ages 35 to 70 years
Conditions the study is for
Diabetes
What is being tested?
A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteSpain
Study dates
2 Feb 2025to 30 Jun 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Prediabetics with glycosylated hemoglobin (HbA1c) 5.7-6.4 (24, 38) and signing informed consent.
  • -

Who cannot join

  • Presence of physical or psychological illnesses that prevent physical activity; participation in another research project; pregnancy or breastfeeding; patients undergoing dietary or pharmacological treatment for weight loss; history of myocardial infarction or stroke; diabetic, taking drugs for diabetes mellitus and taking drugs such as Gliflozin for pathologies other than diabetes mellitus.
  • of physical or psychological illnesses that prevent physical activity; participation in another research project; pregnancy or breastfeeding; patients undergoing dietary or pharmacological treatment for weight loss; history of myocardial infarction or stroke; diabetic, taking drugs for diabetes mellitus and taking drugs such as Gliflozin for pathologies other than diabetes mellitus.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

ANTXON GENERAL PRACTITIONNER contact

945207935

ANTXON.APINANIZFERNANDEZ@OSAKIDETZA.EUS

Spain1 site
  • Antxon Apiñaniz

    Vitoria-Gasteiz, Alava

    ANTXON APIÑANIZ, 945207935

Other trials in Spain

About this study

Official title: EFFECTIVENESS OF A TRIPLE NUTRITIONAL INTERVENTION AND PHYSICAL ACTIVITY FOR GLYCOSYLATED HB CONTROL IN PREDIABETICS: CLINICAL TRIAL

Diabetes represents a substantial burden on health care systems. People with prediabetes IGT (impaired glucose tolerance) or IFG (impaired fasting glucose) are at high risk of developing diabetes, and up to 50% progress to diabetes within 5 years.

OBJECTIVE: To evaluate the effectiveness of a triple intervention (physical activity and ordered healthy diet) to improve glycosylated hemoglobin control in prediabetic patients.

Read more

MATERIAL AND METHODOLOGY: Randomized, open, controlled clinical trial with routine clinical practice (health advice for physical activity and healthy diet). Study population: obese or overweight patients of the OSI Araba aged 35-70 years who are in the contemplation stage.

Response assessment: Primary variable: glycosylated hemoglobin; Secondary variables: Body Mass Index (BMI) (kg/cm2); blood pressure (mm Hg); satisfaction questionnaire score; physical exercise index (IPAQ) (METs). Statistical analysis: The analysis of the main variable (change in HbA1c at 6 months between both groups) will be assessed by analysis of covariance, ANCOVA, adjusting for baseline HbA1c. Sample size: 41 patients per arm (+30% to cover losses to follow-up).

Conditions
Diabetes
Being tested
A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY
Keywords
DIABETES MELLITUS
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITYCombination product

    Intervention group: Health advice and triple intervention: 15 ml apple cider vinegar diluted in a glass of water before meals, order in the sequence of meals (sequence of food intake: first vegetables, second proteins, third fats and finally carbohydrates) and physical activity immediately after meals.

    Description of all interventions:

    Patients in both groups: all patients will receive health advice on sports practice from the WHO, Osakidetza and the Basque Government.

Study groups in NCT06820775
Study groupRoleWhat they receive
INTERVENTIONAL GROUPExperimentalHealth advice and triple intervention: 15 ml apple cider vinegar diluted in a glass of water before meals, order in the sequence of meals (sequence of food intake: first vegetables, second proteins, third fats and finally carbohydrates) and physical activity immediately after meals. Description of all interventions: Patients in both groups: all patients will receive health advice on sports practice from the WHO, Osakidetza and the Basque Government (42-44). Likewise, the nurse will give healthy eating recommendations according to the Osakidetza guide (41): 1.1 Recommendation sports practice: ecommendation 1: >>All persons aged 18 years and older should accumulate a minimum of 150 minutes per week of moderate aerobic physical activity, or 75 minutes of vigorous aerobic physical activity each week, or an equivalent combination of moderate and vigorous activities. Exercise should be in sessions of at least 10 minutes. Recommendation 2: Twice or more times per week, it is advisable to
Receives: Combination Product: A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY
CONTROL GROUPNo interventionPatients will receive the same attention as provided in routine clinical practice,

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glycated hemoglobin (HbA1c)

    Glycated hemoglobin (HbA1c)

    Measured: At baseline, 3 and 6 months

Secondary outcomes (5)
  1. BMI (kg/cm2)

    BMI (kg/cm2)

    Measured: At baseline, 3 and 6 months

  2. Satisfaction of patients

    Score in the satisfaction questionnaire

    Measured: At 6 months

  3. Physical exercise index

    Physical exercise index (IPAQ)

    Measured: At baseline, 3 and 6 months

  4. Compliance with the triple dietary intervention

    Compliance with the triple dietary intervention

    Measured: At 3 and 6 months

  5. Percentage of patients who reach normoglycemia (HbA1c < 5.7)

    Prcentage of patients who reach normoglycemia (HbA1c < 5.7).

    Measured: At 3 and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2025
  2. Study start2 Feb 2025 (estimated)
  3. Primary completion30 Jun 2025 (estimated)
  4. Study completion30 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
82 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06820775
Sponsor's protocol ID
PREDIABET01
Status last verified
Feb 2025
First submitted
6 Feb 2025
Last updated
11 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing A TRIPLE INTERVENTION NUTRITION AND PHYSICAL ACTIVITY in people with Diabetes, run by Bioaraba Health Research Institute at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact ANTXON GENERAL PRACTITIONNER (945207935, ANTXON.APINANIZFERNANDEZ@OSAKIDETZA.EUS), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glycated hemoglobin (HbA1c) (time frame: At baseline, 3 and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in